Home / Papers / Polycystic Ovary Syndrome (PCOS) Transition at Menopause

Polycystic Ovary Syndrome (PCOS) Transition at Menopause

1 Citations2021
D. Shah, S. Rasool
Journal of Mid-Life Health

All women with PCOS must be assessed for IR at the outset and then periodically at 1–3 years intervals depending on their individual risk, keeping in mind the higher risk of T2DM among the South Asian population.

Abstract

of T2DM is increased in perimenopause and beyond in women with PCOS. Although compounded by obesity, studies suggest an obesity‐independent association between PCOS had and IGT and T2DM. Based on this independent increased risk, all women with PCOS must be assessed for IR at the outset and then periodically at 1–3 years intervals depending on their individual risk. Keeping in mind the higher risk of T2DM among the South Asian population, it is recommended that this risk should be assessed on an annual basis.